Varicella (Chickenpox)

Chickenpox affects people of all ages and spreads easily through respiratory droplets or direct contact with the fluid from skin lesions. While most cases are mild, complications such as skin infections, pneumonia, encephalitis, and hospitalisation can occur, especially in adults or those with weakened immunity. Vaccination remains the most effective preventive measure; two doses greatly reduce the risk of infection and almost eliminate severe disease. The Varicella Vaccine (variped) strengthens the body’s immune response against the varicella-zoster virus (VZV), providing long-term protection and helping to curb community transmission.

The Varicella Vaccine helps prevent:

• Primary chickenpox infection
• Viral complications such as pneumonia, encephalitis, and bacterial skin infections
• Hospitalisation and severe disease
• Later reactivation leading to shingles

It induces protective immunity against the varicella-zoster virus (VZV), reducing both incidence and severity of disease.

• Strong protection against chickenpox—especially against severe illness
• Reduces spread in communities, protecting vulnerable or unvaccinated people
• Helps lower healthcare burden and costs due to fewer hospitalisations
• Safe and approved by major global health agencies, including WHO and CDC

Side effects are usually mild and temporary:

The safety precautions patients need to follow before receiving the Varicella (Chickenpox) vaccine:

• Disclose any history of severe allergies, immunodeficiency, or recent use of immunosuppressive drugs
• Avoid vaccination if you develop varicella in pregnancy — postpartum vaccination is preferred.
• Defer vaccination if you have a moderate or severe acute illness
• Minor colds or mild fevers generally do not delay vaccination
• Ensure hydration and a light meal before your visit
• Wear clothing that allows easy access to the upper arm or injection area.
• Remain under observation for about 15 minutes after vaccination for safety monitoring.